Robert Seguso

Director/Board Member at SignPath Pharma, Inc.

Finance

Commercial Services

Profile

Robert Seguso is currently working as a Director at SignPath Pharma, Inc. He previously worked as the President, Chief Executive & Financial Officer at Seguso Holdings, Inc. from 2004 to 2010.

Robert Seguso active positions

Companies	Position	Start
SignPath Pharma, Inc. SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT.	Director/Board Member	28/02/2017

All active positions of Robert Seguso

Former positions of Robert Seguso

Companies	Position	End
Seguso Holdings, Inc. Seguso Holdings, Inc. Financial ConglomeratesFinance Seguso Holdings, Inc. operates as a blank check company. It serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded by Robert Seguso on October 21, 2004 and is headquartered in Bradenton, FL.	Director of Finance/CFO	14/06/2010

See the detail of Robert Seguso's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Seguso's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Seguso Holdings, Inc. Seguso Holdings, Inc. Financial ConglomeratesFinance Seguso Holdings, Inc. operates as a blank check company. It serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded by Robert Seguso on October 21, 2004 and is headquartered in Bradenton, FL.	Finance
SignPath Pharma, Inc. SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT.	Commercial Services